Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts

BACKGROUND: Polo-like kinase 4 PLK4 plays a key role in centriole replication. Hence PLK4 inhibition disrupts mitosis, and offers a novel approach to treating chromosomally unstable cancers, including pancreatic cancer. CFI-400945 is a first in class small molecule PLK4 inhibitor, currently undergoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohse, Ines, Mason, Jacqueline, Mary, Pinjiang Cao, Pintilie, Melania, Bray, Mark, Hedley, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356865/
https://www.ncbi.nlm.nih.gov/pubmed/27902970
http://dx.doi.org/10.18632/oncotarget.13619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356865/
https://www.ncbi.nlm.nih.gov/pubmed/27902970
http://dx.doi.org/10.18632/oncotarget.13619

Ejemplares similares